“…Although the application of FIGO staging to SCCs in the case of MCTs does not clearly relate to the graduated outcome of the disease, patients with FIGO stages II to IV had a lower probability of long-term survival than patients with stage I disease. [ 18 , 23 ] Age, tumor size, clinical stage, histologic differentiation, capsular invasion, and the presence of vascular invasion can provide valuable information for the prediction of the survival of patients with SCCs arising from MCTs. [ 5 , 10 , 18 ] The early diagnosis of the malignant transformation before invasion or metastasis is important for treatment.…”